Close Menu

Reproductive Health

News on noninvasive prenatal testing, carrier screening, and preimplantation genetic screening.

During a conference call, company executives also discussed results from the SMART NIPT trial and their outlook for Natera's three businesses.

The company reported $112.4 million in revenues compared to $83.2 million in Q4 2019, beating the average Wall Street estimate of $106.6 million.

Life Genomics markets a noninvasive prenatal test for chromosomal abnormalities, a genetic disease carrier test, and an Alzheimer's disease risk test.

Four genomics startups will join Illumina's Bay Area program, while five will join the Cambridge, UK program.

The company said it expects core molecular testing revenue between $115 million and $125 million and SARS-CoV-2 revenue between $15 million and $20 million.

Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.

Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.

Science reports that a Dutch research funding agency is combating a ransomware attack.

In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.